Archives
-
EZ Cap™ Human p53 mRNA Assay Design
2026-10-01
Discover how EZ Cap™ Human p53 mRNA (ψUTP) can function as a cargo-first assay control for reproductive-system cancer delivery research. This guide connects p53 biology, barrier-aware model selection, and practical readouts without implying therapeutic efficacy.
-
Bromodomain Inhibitor (+)-JQ1: Mechanism & Uses
2026-10-01
Bromodomain Inhibitor, (+)-JQ1 is a BET bromodomain inhibitor that competitively occupies acetyl-lysine recognition sites in BRD4 and BRDT. Its research utility spans transcriptional regulation, apoptosis assays, inflammation studies, and male contraception models, but the cited prostate cancer study does not directly test (+)-JQ1.
-
Flubendazole Autophagy Research Workflow
2026-09-30
Build reproducible Flubendazole experiments around careful DMSO preparation, autophagic-flux controls, and orthogonal metabolic readouts. This workflow translates findings from hepatic stellate-cell fibrosis research into practical assay decisions without overstating what the reference study demonstrated.
-
Chicken GSDME Drives RNA Virus-Induced Pyroptosis
2026-09-30
A Journal of Virology study identifies chicken GSDME as the major pore-forming effector of RNA virus-induced pyroptosis, resolving a long-standing question created by the absence of GSDMD in chickens. Using viral infection, Poly(I:C) stimulation, pathway analysis, and genetic loss-of-function experiments, the authors connect MDA5 signaling with caspase activation, chGSDME cleavage, pyroptosis, and viral release.
-
L. gasseri, NR1I3, and E-Cadherin in Colitis
2026-09-29
The reference study links Lactobacillus gasseri ATCC33323 with improved DSS-induced colitis through an NR1I3–CDH1–E-cadherin regulatory pathway. Its combination of probiotic intervention, intestinal E-cadherin perturbation, transcriptomic analysis, and in vitro validation provides a mechanistic framework for studying mucosal barrier repair.
-
Tomivosertib in Human DRG Neurons: Study Analysis
2026-09-29
The reference study provides direct ex vivo evidence that MNK inhibition with tomivosertib rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion neurons obtained from patients with radiculopathy. Its combination of human electrophysiology and pharmacodynamic measurement of eIF4E phosphorylation strengthens the case for MNK signaling as a translational target in neuropathic pain, while leaving clinical efficacy and precise ion-channel mechanisms unresolved.
-
Annexin V-APC/SYTOX Green Apoptosis Kit
2026-09-28
The Annexin V-APC/SYTOX Green Apoptosis Kit enables complementary measurement of phosphatidylserine exposure and plasma-membrane permeabilization. This article explains how to interpret the dual readout when studying RNA-responsive pyroptosis and other complex cell-death phenotypes.
-
BV6 IAP Antagonist: Workflows for Cell-Death Studies
2026-09-28
BV6 offers a practical way to test whether IAP-dependent survival helps cancer cells resist apoptosis or treatment. This guide connects its use to dose-response, radiosensitization, and combination workflows while emphasizing controls that distinguish target engagement from cell killing.
-
Berbamine Hydrochloride: Pathway Insight for HCC
2026-09-27
Ferroptosis resistance is an emerging challenge in hepatocellular carcinoma research. This article connects findings on the METTL16–SENP3–LTF axis with a careful, testable approach to Berbamine hydrochloride—distinguishing established product data from hypotheses researchers can investigate.
-
Palonosetron for Chemotherapy-Induced Nausea
2026-09-26
Ruhlmann and Herrstedt review palonosetron’s distinctive receptor pharmacology and assess whether its long action translates into clinically meaningful prevention of chemotherapy-induced nausea and vomiting. Their central message is cautious: pharmacologic differences matter only when they improve patient-relevant outcomes, particularly delayed emesis control, nausea, or tolerability.
-
BRD4–TXNIP Signaling Primes Tumors for Ferroptosis
2026-09-25
The study links BRD4 inhibition to increased TXNIP, reduced histone H4 UFMylation, and weaker c-MYC chromatin activity, explaining how JQ1 can place solid tumor cells in a growth-arrested state. This state is associated with greater ferroptosis sensitivity, suggesting a combination strategy while also highlighting the risk of leaving drug-tolerant, quiescent cells.
-
Doxorubicin Hydrochloride: Assays & Liposome Workflows
2026-09-25
Use Doxorubicin hydrochloride to connect tumor-cell response studies with a practical test of drug loading in dual-loaded liposomes. This guide pairs dose-response and apoptosis workflows with nanoparticle-exclusion chromatography, while flagging the controls needed to distinguish encapsulation from assay artifacts.
-
Streptavidin Magnetic Beads for NSCLC Assay Design
2026-09-24
Benzyl-activated Streptavidin Magnetic Beads provide a practical way to capture biotinylated probes and reagents when testing molecular interactions in cancer research. This article maps the SNORA38B–E2F1–GAB2 findings in NSCLC to careful assay design, controls, and workflow limits.
-
Central Circuits Behind Opioid Mechanical Hypersensitivity
2026-09-24
Yin et al. identify a brain-to-spinal opioid pathway linking lateral parabrachial, hypothalamic, and spinal neurons to morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. Their findings point to a central mechanism that can help distinguish mechanical opioid side effects from thermal responses and guide circuit-focused pain research.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-09-23
Connect herbicide-induced oxidative stress to mitochondrial depolarization with a ratiometric JC-1 workflow, while keeping ROS and membrane-potential measurements distinct. Practical controls, preparation guidance, and troubleshooting help researchers adapt the assay to plant material and other mitochondrial samples.